A pooled analysis of the resistance patterns of Escherichia coli strains isolated from urine cultures in Turkey: a comparison of the periods 1997-2001 and 2002-2007

To compare the resistance patterns of Escherichia coli strains reported to be isolated from urine cultures in published medical literature from Turkey in 1997-2001 and 2002-September 2007. Materials and methods: To find the published series, 3 national databases (Ulakbim Turkish Medical Literature database, http://www.turkishmedline.com, http://medline.pleksus.com.tr), and 2 international databases (Pubmed and Science Citation Index (SCI)) were searched. Results: Data for 25,577 E. coli strains were obtained from 53 articles (28 articles from 1997-2001, 25 from 2002-2007). Of these strains 18,106 were isolated from outpatients, whereas 7471 were from inpatients. When the strains isolated from outpatients were evaluated, there was a significant increase in the ciprofloxacin resistance, whereas there was a significant decrease in amikacin, netilmicin, and co-trimoxazole resistance (P < 0.05). When the data of hospitalized patients were analyzed, there was significant decrease in amikacin, gentamicin, netilmicin, co-trimoxazole, and amoxicillin/clavulanate resistance, whereas a significant increase was observed in nitrofurantoin resistance (P < 0.05). The ESBL rate increased in both the inpatients and outpatients (P < 0.05). Conclusion: When looked at from Turkey's perspective, our data suggest that aminoglycosides and third-generation cephalosporins may be good choices in the treatment of inpatients. Fosfomycin/tromethamine, nitrofurantoin, and oral third-generation cephalosporins may be reasonable alternatives in the empirical treatment of uncomplicated outpatient cases. Policies to constrain resistance in both the community, and hospitals, such as antibiotic stewardship or restriction programs, should be implemented immediately.

A pooled analysis of the resistance patterns of Escherichia coli strains isolated from urine cultures in Turkey: a comparison of the periods 1997-2001 and 2002-2007

To compare the resistance patterns of Escherichia coli strains reported to be isolated from urine cultures in published medical literature from Turkey in 1997-2001 and 2002-September 2007. Materials and methods: To find the published series, 3 national databases (Ulakbim Turkish Medical Literature database, http://www.turkishmedline.com, http://medline.pleksus.com.tr), and 2 international databases (Pubmed and Science Citation Index (SCI)) were searched. Results: Data for 25,577 E. coli strains were obtained from 53 articles (28 articles from 1997-2001, 25 from 2002-2007). Of these strains 18,106 were isolated from outpatients, whereas 7471 were from inpatients. When the strains isolated from outpatients were evaluated, there was a significant increase in the ciprofloxacin resistance, whereas there was a significant decrease in amikacin, netilmicin, and co-trimoxazole resistance (P < 0.05). When the data of hospitalized patients were analyzed, there was significant decrease in amikacin, gentamicin, netilmicin, co-trimoxazole, and amoxicillin/clavulanate resistance, whereas a significant increase was observed in nitrofurantoin resistance (P < 0.05). The ESBL rate increased in both the inpatients and outpatients (P < 0.05). Conclusion: When looked at from Turkey's perspective, our data suggest that aminoglycosides and third-generation cephalosporins may be good choices in the treatment of inpatients. Fosfomycin/tromethamine, nitrofurantoin, and oral third-generation cephalosporins may be reasonable alternatives in the empirical treatment of uncomplicated outpatient cases. Policies to constrain resistance in both the community, and hospitals, such as antibiotic stewardship or restriction programs, should be implemented immediately.

___

  • Pullukcu, H, Aydemir S, Tasbakan MI, Çilli F, Tunger A, Ulusoy S. Susceptibility of extended-spectrum beta-lactamase producing Escherichia coli urine isolates to fosfomycin, ciprofl oxacin, amikacin and trimethoprim sulfamethoxazole. Turk J Med Sci 2008; 38: 175-180. 6. Yüksel S, Öztürk B, Kavaz A, Ozçakar ZB, Acar B, Güriz H et al. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections. Int J Antimicrob Agents 2006; 28: 413-6.
  • Clinical and Laboratory Standards Institute/NCCLS: Performance Standards for Antimicrobial Susceptibility Testing. 15. Informational Supplement, CLSI/NCCLS,M100-S15, Wayne: PA; 2005.
  • Yuluğkural Z, Mutlu B. Susceptibility of Escherichia coli strains isolated from urine cultures to some commonly used antibacterial agents Medical Journal of Trakya University 2007; 24: 6-11. Yılmaz E, Özakın C, Sınırtaş M, Gedikoğlu S. Microorganisms isolated from urine specimens in the bacteriology laboratory, Uludağ University Hospital, between 1999 and 2002. Turkish Journal of Infection 2005; 19: 91- 6.
  • Ertuğrul MB, Çolak N. Antibiotic susceptibility rates of community-acquired uropathogenic Escherichia coli isolates. ANKEM Derg 2004; 18: 161-5.
  • Taşbakan MI, Pullukçu H, Yamazhan T, Arda B, Ulusoy S. Comparison of in-vitro activity of fosfomycin and other antibacterials in Escherichia coli strains isolated from community acquired urinary tract infections. ANKEM Derg 2004; 18: 216-219.
  • Bayraktar B, Özcan N, Borahan S, Başarı F, Bulut E. Resistance in Gram negative bacilli isolated from urinary tract infections in hospitalized and policlinic patients ANKEM Derg 2004; 18: 137-140.
  • Saraçlı MA, Baylan O, Gün H. Gram negative bacilli causing urinary tract infections and their antibiotic susceptibilities. ANKEM Derg 1999; 13: 73-78.
  • Kaygusuz S, Apan TZ, Kılıç D. Resistance to various antibiotics of Gram-negative bacteria isolated from community-acquired urinary tract infections. ANKEM Derg 2001; 15: 753-9.
  • Erden S, Çalangu S. Poliklinik hastalarında üriner sistem infeksiyonlarından izole edilen Escherichia coli suşlarının çeşitli antibiyotiklere in vitro duyarlılıkları. İst Tıp Fak Mecmuası 2002; 65: 147-149.
  • Özden M, Kalkan A, Demirdağ K, Kılıç SS, Özdarendereli A. Ciprofl oxacin and co-trimoxazole resistance in Escherichia coli strains isolated from urinary tract infections. ANKEM Derg 2003; 17: 51-55.
  • Ağel E, Durmaz B, Kutlu O, Balat A, Aşgın N. Antimicrobial activity of loracarbef and its effi ciency in pediatric patients with urinary tract infections. ANKEM Derg 2000; 14: 79-84.
  • Cesur S, Albayrak F, Özdemir D, Kolcu Z, Tekeli E. Antibiotic susceptibilities of Gram negative roads isolated from urine samples obtained from hospitalized patients. Türk Mikrobiyol Cem Derg 2002; 33: 174-6.
  • Demirtürk N, Demirdal T, Eldemir H, İnce R, Altındiş M. Bacteria isolated from urine samples and their antibiotic susceptibilities. Türk Mikrobiyol Cem Derg 2005; 35: 103-6.
  • Kurutepe S, Sürücüoğlu S, Sezgin C, Gazi H, Gulay M, Özbakkaloğlu B. Increasing antimicrobial resistance in Escherichia coli isolated from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey. Jpn J Infect Dis 2005; 58: 159-161.
  • Otağ F, Yıldız Ç, Delialioğlu N. Antibiotic resistance of Escherichia coli strains isolated from urine samples. ANKEM Derg 2003; 17: 384-7.
  • Baykan M, Kaya M, Arslan U, Baysal B. Sensitivity of antimicrobics to E. coli strains isolated from urine samples. İnönü Üniversitesi Tıp Fakültesi Dergisi 2001; 8: 15-7.
  • Aydos SE, Yavuzdemir Ş, Nohutçu Y, Çavuş İ. In vitro sensitivity of bacteria to various antibiotics, obtained from women suff ering from cystitis. Türk Jinekoloji ve Obstetrik Derneği Dergisi 2006; 3: 118-21.
  • Özkalp B, Topçu A. Th e Gram negative bacteria those isolated from urinary tract infections and their susceptibility to various antibiotics. Selçuk Üniversitesi Tıp Fakültesi Dergisi 2000; 16: 171-4.
  • Çetin H, Öktem F, Örmeci AR, Yorgancıgil B, Yaylı G. Escherichia coli and antibiotic resistance in childhood urinary tract infections. Süleyman Demirel Üniveristesi Tıp Fak Derg 2006; 13: 12-6.
  • İnan UN, Gürler N. Investigation of antibiotic resistance and some virulence factors of Escherichia coli strains isolated from children with urinary tract infections. ANKEM Derg 2004; 18: 89-96.
  • Gürgöze MK, Doğan Y, Kizirgil A, Toraman ZA, Aygün D. Antibiotic sensitivities of bacteria isolated from children with urinary tract infections. Fırat Tıp Dergisi 2002; 7: 828-832.
  • Gündüz T, Mumcuoğlu İ. Antimicrobial susceptibility of Escherichia coli strains isolated from urine samples. Türk Mikrobiyol Cem Derg 2004; 34: 157-161.
  • Elaldı N, Turan M, Duran B, Bakır M, Dökmetaş İ, Bakıcı MZ, Şahin F. Nosocomial urinary tract infections in a university hospital: Causative microorganisms and antimicrobial resistance. Cumhuriyet Üniversitesi Tıp Fakültesi Dergisi 2003; 25: 63-8.
  • Demirci M, Arıdoğan BC, Arda M. Antibiotic sensitivity of gram negative bacilli isolated from outpatients urine cultures. ANKEM Derg 2000; 14: 576-9.
  • Taşova Y, Saltoğlu N, Yaman A, Yılmaz G, Dündar İH. Nosocomial urinary tract infections in the Medical Faculty Hospital, Çukurova University. Turkish J Infect 1999; 13: 249- 254.
  • Erdem H, Avcı A, Pahsa A. Th e Antibacterial resistance in community acquired uropathogenic Escherichia coli strains. ANKEM Derg 2004; 18: 40-4.
  • Akan ÖA. Antibiotic Resistance of urinary Escherichia coli isolated from outpatient samples against fi rst line drugs. Ankara Üniversitesi Tıp Fakültesi Mecmuası 2003; 56: 147-50. Sucu N, Boz GA, Bayraktar Ö, Çaylan R, Aydın K, Köksal İ. Th e change of antibiotic susceptibilities of uropathogen Escherichia coli strains in years. Klimik Dergisi 2004; 17: 128-131.
  • Tolun V, Akbulut DT, Çatal Ç, Turan N, Küçüker MA, Ang Ö. Th e antibiotic susceptibilities of gram negative rods isolated as causative agents of urinary tract infections from in- and outpatients. Türk Mikrobiyol Cem Derg 2002: 32: 69-74.
  • Eroğlu C, Günaydın M, Birinci A, Esen Ş, Sünbül M, Leblebicioğlu H. determination of extended spectrum beta lactamases (ESBL) in Escherichia coli strains isolated from urinary system infections. Turk Mikrobiyol Cem Derg 2003; 33: 118-121.
  • Kibar F, Yaman A, Dündar İH. Bacteria isolated from urine samples and their antibiotic susceptibilities. Turk Mikrobiyol Cem Derg 2004; 34: 162-170.
  • Çitil BE, Çöplü N, Gözalan A, Öncül Ö, Karaca Y, Esen B. Th e evaluation of antibiotic resistance in urinary tract infection agent Enterobacteriaceae spp. for two years. Th e Medical Journal of Kocatepe 2006; 7: 31-5.
  • Şencan İ, Sevinç ME. Antimicrobial resistance survey of community-acquired uropathogen Escherichia coli isolated. Klimik Dergisi 2002; 15: 85-8.
  • Altındiş M, Tanır HM. Microbiological evaluation of urine samples taken from patients with urinary tract infections symptoms and susceptibilities to various antibiotic against of the gram-negative microorganisms isolated from those women. Türk Microbiyol Cem Derg 2001; 31: 192-7.
  • Savaş L, Güvel S, Turunç T, Savaş N, Arslan H. Comparison of the causative microorganisms and their antibiotic susceptibility between community acquired and nosocomial urinary tract infections. Türk Üroloji Dergisi 2003; 29: 95-100.
  • Ertuğrul MB, Güleç LA, Akal D, Çagatay AA, Özsüt H, Eraksoy H, Çalangu S. Susceptibility of uropathogen Escherichia coli isolates to the antimicrobials used commonly in urinary tract infections. Klimik Dergisi 2004; 17: 132-6.
  • Tünger Ö, Sürücüoğlu S, Özbakkaloğlu B, Gazi H. Extended spectrum beta lactamase production and susceptibility to antibiotics in Escherichia coli strains isolated from community acquired and nosocomial infections. Mikrobiyol Bült 2001; 35: 351-7.
  • Pullukçu H, Aydemir Ş, Taşbakan MI, Sipahi OR, Çilli F, Ulusoy S. In vitro effi cacy of nitrofurantoin Escherichia coli strains isolated from urine cultures. Turk J Infect 2007; 21: 197-200.
  • Gazi H, Sürücüoğlu S, Kurutepe S. Antimicrobial resistance of Gram Negative bacteria isolated from urine cultures. ANKEM Derg 2007; 21: 19-22.
  • Koçoğlu E, Karabay O, İnce NK, Özkardeş F, Yıldırım R. Th e frequency of extended spectrum beta-lactamase production and antibiotic susceptibility of Escherichia coli strains isolated from community-acquired urinary tract infections. ANKEM Derg 2007; 21: 5-9.
  • Turunç T, Turunç T. Nosocomial urinary tract infections related with urinary catheter in patients from intensive care units. Türk Üroloji Dergisi 2003; 29: 209-14.
  • Ay S, İşeri LA, Duman B. Antibiotic Susceptibilities of Gram Negative microorganisms isolated from urine samples. İnönü Üniversitesi Tıp Fakültesi Dergisi 2003; 10: 59-62.
  • Şahin İ, Öksüz Ş, Kaya D, Şencan İ, Gülcan A. Antibiotic susceptibility of uropathogenic Gram Negative rods isolated from inpatient and outpatient children. ANKEM Derg 2004; 18: 101-104.
  • Yetkin G, Kuzucu Ç, Çalışkan A. An investigation on Escherichia coli strains with extended spectrum beta lactamase growth in urinary cultures. İnönü Üniversitesi Tıp Fakültesi Dergisi 2006; 13: 249-252.
  • Arca AE, Karabiber N. Short Communication: Comparison of susceptibilities of Escherichia coli urinary tract isolates against fosfomycin tromethamine and diff erent antibiotics. Microbiyol Bült 2007; 41: 115-119.
  • Gulsun S, Oğuzoğlu N, Ceran N, İnan A, Göktaş P. Th e virulence factors and antibiotic sensitivities of Escherichia coli strains isolated from recurrent urinary tract infections. Saudi Med J 2005; 26: 1755-8.
  • Öktem MA, Gülay Z, Ercan H, Biçmen M, Yuluğ N. Microorganisms isolated in intensive care units and their antibiotic susceptibility. Turk J Infect 2001; 15: 61-66.
  • Timurkaynak F, İnci EK, Arslan H. Characteristics and antibiotic susceptibility of pathogens isolated from community acquired and nosocomial urinary tract infections. Ankara Üniversitesi Tıp Fakültesi Mecmuası 2001; 54: 287-292.
  • Aral M, Çıragil P, Gül M, Ekerbiçer HÇ, Çelik M, Koçtürk SA. Th e spectrum of bacteria isolated from urinary tract infections in children aged 0-5 years and antibiotic resistance status of Gram Negative bacteria. Kahramanmaraş Sütçü İmam Üniversitesi Tıp Fakültesi 2005; 2: 5-9.
  • Şener A, Yapar N, Çakır N, Yüce A. Searching asymptomatic bacteriuria in Yeşilyurt nursery home geriatric residents and susceptibility patterns of bacteriae. Medical Journal of İzmir Hospital 2004; 10: 69-71.
  • Sümer Z, Çoşkunkan C, Vahaboglu H, Bakır M. Th e resistance of Escherichia coli strains isolated from community-acquired urinary tract infections. Adv Th er 2005; 22: 419-23.
  • Ozyurt M, Haznedaroğlu T, Sahiner F, Oncül O, Ceylan S, Ardiç N, Erdemoğlu A. Antimicrobial resistance profi les of community-acquired uropathogenic Escherichia coli isolates during 2004-2006 in a training hospital in İstanbul Mikrobiyol Bul 2008; 42: 231-43.
  • Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeff er AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999; 29: 745-58.
  • Puerto AS, Fernández JG, del Castillo Jde D, Pino MJ, Angulo GP. In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli. Diagn Microbiol Infect Dis 2006; 54: 135-9.
  • Alhambra A, Cuadrs JA, Cacho J, Gómez-Garcés JL, Alós JI. In vitro susceptibility of recent antibiotic-resistant urinary pathogens to ertapenem and 12 other antibiotics. J Antimicrob Chemother 2004; 53: 1090-4.
  • Hernández JR, Martínez-Martínez L, Cantón R, Coque TM, Pascual A. Spanish Group for Nosocomial Infections (GEIH). Nationwide study of Escherichia coli and Klebsiella pneumoniae producing extended-spectrum beta-lactamases in Spain. Antimicrob Agents Chemother. 2005; 49: 2122-5.
  • Kamberovic SU. Antibiotic resistance of coliform organisms from community-acquired urinary tract infections in Zenica- Doboj Canton, Bosnia and Herzegovina. JAC 2006; 58: 344-8.
  • Andrade SS, Sader HS, Jones RN, Pereira AS, Pignatari AC, Gales AC. Increased resistance to fi rst-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines? Mem Inst Oswaldo Cruz. 2006; 101: 741-8.
  • Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infections in J N M C Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007; 6: 4.
  • Canbaz S, Peksen Y, Tevfi k Sunter A, Leblebicioglu H, Sunbul M. Antibiotic prescribing and urinary tract infection. Int J Antimicrob Agents. 2002; 20: 407-11.
  • Nordmann P, Poirel L. Emergence of plasmid-mediated resistance to quinolones in Enterobacteriaceae. J Antimicrob Chemother 2005; 56: 463-9.
  • Marchese A, Gualco L, Debbia EA, Schito GC, Schito AM. In vitro activity of fosfomycin against gram-negative urinary pathogens and the biological cost of fosfomycin resistance. Int J Antimicrob Agents. 2003; 22 Suppl 2: 53-9
  • Das RN, Chandrashekhar TS, Joshi HS, Gurung M, Shrestha N, Shivananda PG. Frequency and susceptibility profi le of pathogens causing urinary tract infections at a tertiary care hospital in western Nepal. Singapore Med J. 2006; 47: 281-5.
  • Gobernado M, Valdés L, Alós JI, García-Rey C, Dal-Ré R, García-de-Lomas J;Spanish Surveillance Group for Urinary Pathogens. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain. Rev Esp Quimioter 2007; 20: 68-76.
  • Farrell DJ, Morrissey I, De Rubeis D, Robbins M, Felmingham D. A UK multicentre study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect 2003; 46: 94-100.
  • Tasbakan M, Pullukcu H, Sipahi O, Yamazhan T, Ulusoy S. Nitrofurantoin In the treatment of Extended-Spectrum Beta- Lactamase (ESBL) Producing E. coli related lower urinary tract infection (luti). 48th Interscience Conference on Antimicrobial Agents and Chemotherapy, 46th Infectious Diseases Society of America Annual Meeting. Washington, poster L494.
  • Sipahi OR. Economics of antibiotic resistance. Exp Rev Anti- Infect Th er 2008; 6: 523-539.
  • Talan DA, Krishnadasan A, Abrahamian FM, Stamm WE, Moran GJ. EMERGEncy ID NET Study Group. Prevalence and risk factor analysis of trimethoprim-sulfamethoxazole- and fl uoroquinolone-resistant Escherichia coli infection among emergency department patients with pyelonephritis. Clin Infect Dis 2008; 47:1150-8.
  • Guajardo-Lara CE, González-Martínez PM, Ayala-Gaytán JJ. Antibiotic resistance of Escherichia coli from community- acquired urinary tract infections. What antimicrobial to use? Salud Publica Mex. 2009; 51: 155-9.
  • Ungheri D, Albini E, Belluco G. In-vitro susceptibility of quinolone-resistant clinical isolates of Escherichia coli to fosfomycin trometamol. J Chemother. 2002; 14: 237-40.
  • Pullukcu H, Tasbakan M, Sipahi OR, Yamazhan T, Aydemir Ş, Ulusoy S. Fosfomycin in the treatment of extended spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infections. Int J Antimicrob Agents 2007; 29: 62- 65.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

An investigation of genes coding fi bronectin binding proteins in Staphylococcus aureus isolated from carriers aged between 6 and 14 years

Vildan AVKAN OĞUZ, Nur YAPAR

The effects of taping and foot exercises on patients with hallux valgus: a preliminary study

Banu BAYAR, Suat EREL, İbrahim Engin ŞİMŞEK, Erkan SÜMER, Kılıçhan BAYAR

Serum osteoprotegerin (OPG) measurement in Behçet's disease

Nafiye Fulya İLHAN, Nesrin DEMİR, Tamer DEMİR, Ahmet GÖDEKMERDAN

A comparison of two different fluorochrome stains for the detection of acid-fast bacilli in sputum specimens*

Vildan Avkan OĞUZ, Nurbanu SEZAK, Aygün ÖZTOP, Nur YAPAR

Th e eff ect of alkali burn on corneal glutathione peroxidase activities in rabbits

İlknur AKYOL SALMAN, Orhan BAYKAL, Ahmet KIZILTUNÇ

Metabolic profi le and insulin resistance in patients with obstructive sleep apnea syndrome

Şahin ÖĞREDEN, Hale ARAL, Özgür YİĞİT, Güvenç GÜVENEN, Berrin BERÇİK İNAL, Mustafa ŞAHİN

Clitoral length in female newborns: a new approach to the assessment of clitoromegaly

Fatih AKBIYIK, Hatice Alev KUTLU

Potential role of some nutraceuticals in the regression of Alzheimer&#8217;s disease in an experimental animal model

Hanna Hamdy AHMED, Wafaa Ghoneim SHOUSHA, Rehab Mahmoud HUSSIEN, Abdel Razik Hussein FARRAG

Potential role of some nutraceuticals in the regression of Alzheimer’s disease in an experimental animal model

Abdel Razik Hussein FARRAG, Hanna Hamdy AHMED, Wafaa Ghoneim SHOUSHA, Rehab Mahmoud HUSSIEN

Evaluation of the genotype MTBDRplus assay for the diagnosis of tuberculosis and rapid detection of rifampin and isoniazid resistance in clinical specimens*

Cengiz ÇAVUŞOĞLU, Derya GÜRSEL, Hale Bozkurt AKTOPRAK